K2 & Associates
VC Fund
Toronto, Canada
K2 & Associates is a hedge fund manager with an 18 year track record of successfully managing money and creating value for their shareholders and stakeholders at large. Their returns rank in the top decile of all comparable funds during this period.Their repeatable investment model includes a diverse range of strategies employed in differentweights across a variety of market cycles. They are activists who work to surface value, and they have competitive advantage in many areas that create alpha. They have a solid reputation as a good partner, lead investor and strong sponsor for companies looking for risk capital.Their passionate and dedicated team of investment professionals and risk managers have a broad array of skill sets ranging from the CA and CFA to Engineering and MBA designations. Moreover, they maintain relationships with domain experts across all industries. Their firm's principals have all their material capital invested in the firm and represent over 50% of all capital in the fund.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries K2 & Associates invests in
Stages K2 & Associates invests in
Countries K2 & Associates invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Shawn Kimel
|
|||
4 more contacts available
Investment Focus
Industry
- Health Care 3 (50%)
- Marketplace 2 (33%)
- Apps 1 (17%)
- Retail 1 (17%)
- Medical 1 (17%)
Stage
- Seed 2 (33%)
- Series A 2 (33%)
- Post-IPO Equity 1 (17%)
- Venture - Series Unknown 1 (17%)
Country
- United States 5 (83%)
- Canada 1 (17%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Shawn Kimel
Founder & CIO
|
Founder & CIO | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Vimy Pharma
|
Vimy Pharma is a manufacturer of high qulaity complex medicines. | Seed / Oct 17, 2025 | |
MycroDose Therapeutics
|
Mycrodose Therapeutics is a US-Based pharmaceutical company specialized in the development of advanced drug delivery (ADD) systems utilizing psychedelic compounds to treat mental health and cognitive degenerative diseases. The company is in the parallel development of two of its four core technologies; a psilocybin transdermal delivery system,Ketamine oral mucosa delivery system. | Seed / Sep 21, 2021 | |
Nobul Technologies
|
Nobul is a technology-driven real estate marketplace in which any agent from any brokerage can compete for the consumer's business. It provides consumers with options, agents with accountability, and overall real estate transparency.Regan McGee founded the company in 2017. It aims to empower customers by providing them with all of theinformation they need to learn about such as sales history and verified reviews. | $40M / Venture - Series Unknown / Aug 30, 2021 | |
Rebels
|
Rebel is a modern marketplace that takes the haggle and the hassle out of parenting by enabling the buy and sell of overstock, open box, and quality used baby gear. A certified pending B Corporation, the business is centered around minimizing the “stuff burden” for the next generation. Rebelstork’s founder Emily saw a huge void in the dating babyindustry and built Rebel to address the rapidly changing consumer needs in this space and the need to encourage the circular economy. | $3.7M / Series A / Jun 24, 2021 | |
WeSana Health
|
WeSana Health is a life sciences company that provides advancement of psilocybin-based medicine. The company was founded in 2020 by Daniel Carcillo and is headquartered in Homer Glen, Illinois, United States. | $12.8M / Post-IPO Equity / Mar 31, 2021 | |
Semasio (formerly Fyllo)
|
Semasio is on a mission to power outperformance in a privacy-first world. With access to the world's most comprehensive targeting platform available, our industry-leading advertising solutions are trusted by Fortune 500 companies and emerging brands to increase reach, boost efficiency, and maximize ROI.The company was founded in 2019 and isheadquartered in Chicago, Illinois. | $10M / Series A / Aug 12, 2020 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does K2 & Associates invest in?
K2 & Associates invests primarily in Health Care, Marketplace and Apps startups, most often at Seed and Series A stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact K2 & Associates?
Public channels for K2 & Associates include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at K2 & Associates?
The team at K2 & Associates includes Shawn Kimel (Founder & CIO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
